PubMed Health⌕ Search
Home/Archive/PubMed

PubMed · 3910983

[Malignant lymphoma and tuberculosis].

K Hörmann·M Garbrecht
View original source ↗Export metadata ↓

Abstract

In 153 patients with malignant lymphoma (1981-1984) one case of simultaneous occurrence of a Non-Hodgkin lymphoma of high grade malignancy and tuberculosis of a cervical lymph node is reported. Typical morphological characteristics were absent. In the first biopsy mycobacterium tuberculosis was demonstrated in a microbiological animal trial. In a second biopsy a centroblastic lymphoma was found. It is possible that the onset of lymph node tuberculosis is promoted by the impaired immunological defence mechanism of the malignant growth. On the other hand, the malignant lymphoma might be caused by the chronic tuberculous inflammation. Independent of this question, a persistent cervical lymphoma must be identified by biopsy and microbiology. An essential factor in deciding both therapy and prognosis of the malignant lymphoma is to diagnose the presence of a tuberculous infection, for the concurrent treatment of primary and secondary disease provides the only chance of cure.

Explore related subjects

BiopsyDiagnosis, DifferentialFemaleHead and Neck NeoplasmsHumansLymph NodesLymphoma, Large B-Cell, DiffuseMiddle AgedTuberculosis, Lymph NodeCase ReportsEnglish AbstractJournal Article

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

K Hörmann, M Garbrecht. 1985. [Malignant lymphoma and tuberculosis].. https://pubmed.ncbi.nlm.nih.gov/3910983/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed2007

Non-radical diagnostic biopsies do not negatively influence melanoma patient survival.

BACKGROUND: In fair-skinned Caucasian populations both the incidence and mortality rates of cutaneous melanoma have been increasing over the past decades. With adjuvant therapies still being under investigation, early detection is the only way to improve melanoma patient survival. The influence of incisional biopsies on melanoma patient survival has been discussed for many years. This study investigates both the influence of diagnostic biopsy type and the presence of residual tumor cells in the re-excision specimen on disease free and overall survival. METHODS: After (partial) removal of a pigmented skin lesion 471 patients were diagnosed with stage I/II melanoma and underwent re-excision and a sentinel node biopsy. All patients were followed prospectively, mean follow up >5 years. Patients were divided according to their diagnostic biopsy type (wide excision biopsy, narrow excision biopsy, excision biopsy with positive margins and incisional biopsy) and the presence of residual tumor cells in their re-excision specimen. Survival analysis was done using Cox's proportional hazard model adjusted for eight important confounders of melanoma patient survival. RESULTS: The diagnostic biopsy was wide in 279 patients, narrow in 109 patients, 52 patients underwent an excision biopsy with positive margins and 31 patients an incisional biopsy. In 41 patients residual tumor cells were present in the re-excision specimen. Both the diagnostic biopsy type and the presence of tumor cells in the re-excision specimen did not influence disease free and overall survival of melanoma patients. CONCLUSIONS: Non-radical diagnostic biopsies do not negatively influence melanoma patient survival.

Biopsy↗